Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
15145.0000 -30.00 (-0.20%)
NSE Jan 01, 2026 14:39 PM
Volume: 9,879
 

15145.00
-0.20%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Neuland Laboratories Ltd. is trading above its 200 day SMA of 13918.7
More from Neuland Laboratories Ltd.
Recommended